Abstract:Background Infertility in mammalian females has been a challenge in reproductive medicine. The causes of female infertility include anovulation, ovulated oocyte defects, abnormal fertilization, and insufficient luteal support for embryo development, as well as early implantation. Ovulation induction, in vitro fertilization and luteal support regimens have been performed for decades to increase fertility rates. The identification of proteins and biochemical factors involved in female reproduction is essential to further increase female fertility rates. Evidence has shown that prostaglandins (PGs) might be involved in the female reproductive process, mainly ovulation, fertilization, and implantation. However, only a few studies on individual PGs in female reproduction have been done so far. This review aimed to identify the pivotal role of prostaglandin E2 (PGE2), a predominant PG, in female reproduction to improve fertility, specifically ovulation, fertilization, embryo development and early implantation. Results Prostaglandin E2 (PGE2) was shown to play a relevant role in the ovulatory cascade, including meiotic maturation, cumulus expansion and follicle rupture, through inducing ovulatory genes, such as Areg , Ereg , Has2 and Tnfaip6, as well as increasing intracellular cAMP levels. PGE2 reduces extracellular matrix viscosity and thereby optimizes the conditions for sperm penetration. PGE2 reduces the phagocytic activity of polymorphonuclear neutrophils (PMNs) against sperm. In the presence of PGE2, sperm function and binding capacity to oocytes are enhanced. PGE2 maintains luteal function for embryo development and early implantation. In addition, it induces chemokine expression for trophoblast apposition and adhesion to the decidua for implantation. Conclusion It has been shown that PGE2 positively affects different stages of female fertility. Therefore, PGE2 should be taken into consideration when optimizing reproduction in infertile females. We suggest that in clinical practice, the administration of non-steroidal anti-inflammatory drugs, which are PGE2 synthesis inhibitors, should be reasonable and limited in infertile women. Additionally, assessments of PGE2 protein and receptor expression levels should be taken into consideration.

Cyclooxygenase-2-derived Prostaglandin E2 Directs Oocyte Maturation by Differentially Influencing Multiple Signaling Pathways

Cyclooxygenase pathway and its regulation on female mammalian reproduction

Drosophila Pxt: a cyclooxygenase-like facilitator of follicle maturation

Synergistic effect between LH and estrogen in the acceleration of cumulus expansion via GPR30 and EGFR pathways

Paracrine Regulation of the Resumption of Oocyte Meiosis by Endothelin-1

Interaction between epidermal growth factor receptor and C-C motif chemokine receptor 2 in the ovulatory cascade

Cyclooxygenase-2 is acutely induced by CCAAT/enhancer-binding protein β to produce prostaglandin E 2 and F 2α following gonadotropin stimulation in Leydig cells

The Signal Pathway of Gonadotrophins-Induced Mammalian Oocyte Meiotic Resumption

Differential expression and regulation of prostaglandin E synthases in the mouse ovary during sexual maturation and luteal development.

PKCδ and Θ Possibly Mediate FSH-induced Mouse Oocyte Maturation Via NOX-ROS-TACE Cascade Signaling Pathway.

Insulin-Like Growth Factor 1 Promotes Cumulus Cell Expansion And Nuclear Maturation Of Oocytes Via Pi3k/Akt Pathway

Prostaglandin E2 involvement in mammalian female fertility: ovulation, fertilization, embryo development and early implantation

PDE5 modulates oocyte spontaneous maturation via cGMP-cAMP but not cGMP-PKG signaling.

Regulation of germ cell development by intercellular signaling in the mammalian ovarian follicle

Melatonin Receptor 2 Promotes Lipid Metabolism of Cumulus-oocyte Complexes via the cAMP/PKA Pathway

Mechanisms of Estradiol-induced EGF-like Factor Expression and Oocyte Maturation via G Protein-coupled Estrogen Receptor

[Function and molecular mechanism of mitogen-activated protein kinase (MAPK) in regulating oocyte meiotic maturation and ovulation].

Interleukin-6: an Autocrine Regulator of the Mouse Cumulus Cell-Oocyte Complex Expansion Process

FGF2/FGFR signaling promotes cumulus-oocyte complex maturation in vitro.

Regulation of the aryl hydrocarbon receptor activity in bovine cumulus-oocyte complexes during in vitro maturation: The role of EGFR and post-EGFR ERK1/2 signaling cascade

CCN2 Mediates S1P-Induced Upregulation of COX2 Expression in Human Granulosa-Lutein Cells